Morning Briefing
Summaries of health policy coverage from major news organizations
Single-Dose Of Experimental Malaria Drug Clears Parasites In Mice, Represents Potential New Class Of Drugs To Treat Malaria In Humans
An experimental malaria drug was shown to effectively treat the disease in mice with only a single dose, according to a study published Thursday in the journal Science, Reuters reports (Kelland, 9/2). The new drug, known as NITD609, "represents an entirely new class of medicines to treat malaria ... Human trials, backed by Swiss pharmaceutical giant Novartis AG, could begin later this year," the Wall Street Journal writes (Naik, 9/3).
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
